Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Short Interest Update

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the target of a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 299,800 shares, a growth of 1,663.5% from the September 30th total of 17,000 shares. Based on an average daily trading volume, of 420,400 shares, the days-to-cover ratio is currently 0.7 days.

Ono Pharmaceutical Price Performance

Shares of OPHLY traded down $0.03 during trading hours on Friday, hitting $4.18. The company had a trading volume of 413,338 shares, compared to its average volume of 147,536. Ono Pharmaceutical has a 52-week low of $4.10 and a 52-week high of $6.43. The firm has a fifty day moving average price of $4.57 and a 200-day moving average price of $4.69.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.